Ionis Pharmaceuticals (IONS) Current Taxes (2009 - 2026)

Ionis Pharmaceuticals' Current Taxes history runs 11 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• In Q1 2026, Current Taxes rose 2180.95% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (up 2180.95% YoY), while the FY2025 annual figure was $2.7 million, up 7879.41% from the prior year.
• Current Taxes was $2.9 million for Q1 2026 at Ionis Pharmaceuticals, up from $2.7 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $31.1 million in Q3 2023 to a low of $14000.0 in Q2 2022.
• Historically, Current Taxes has averaged $5.3 million across 5 years, with a median of $901000.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Current Taxes jumped 194087.5% in 2023, then plunged 99.87% in 2024.
• A 5-year view of Current Taxes shows it stood at $6.2 million in 2022, then tumbled by 65.58% to $2.2 million in 2023, then tumbled by 98.42% to $34000.0 in 2024, then surged by 7879.41% to $2.7 million in 2025, then gained by 5.93% to $2.9 million in 2026.
• The last three Current Taxes figures came in at $2.9 million (Q1 2026), $2.7 million (Q4 2025), and $101000.0 (Q3 2025), per Business Quant data.